SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,404 | -44.7% | 32,350 | +19.8% | 0.00% | – |
| Q2 2023 | $35,100 | -41.7% | 27,000 | -21.1% | 0.00% | – |
| Q1 2023 | $60,192 | -29.2% | 34,200 | +26.3% | 0.00% | – |
| Q4 2022 | $85,034 | -35.6% | 27,081 | +0.3% | 0.00% | – |
| Q3 2022 | $132,000 | -98.3% | 27,000 | -96.2% | 0.00% | -100.0% |
| Q2 2015 | $7,944,000 | -29.3% | 716,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $11,232,000 | +3.1% | 716,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $10,895,000 | +31.2% | 716,300 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $8,302,000 | -43.1% | 769,800 | -19.4% | 0.00% | -33.3% |
| Q2 2014 | $14,589,000 | -26.4% | 955,400 | -12.8% | 0.01% | -33.3% |
| Q1 2014 | $19,817,000 | – | 1,096,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |